5 Results for "

Vomiting model

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "Vomiting model" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-B0595
CAS No.: 132907-72-3
Synonyms: YM060
Ramosetron (YM060 free base) Hydrochloride is an orally active 5-HT3 antagonist that improves dysphoria, interference with activity and food avoidance. Ramosetron Hydrochloride is promising for research of irritable bowel syndrome with diarrhea .
loading...
    loading...
Cat. No.: HY-121907
CAS No.: 56255-31-3
Target:  

Drug Intermediate

Research Areas:  

Others

N-Palmitoyl L-alanine is an organogelator. The granisetron organogel prepared based on N-Palmitoyl L-alanine has good biocompatibility and can effectively exert an antiemetic effect .
loading...
    loading...
Cat. No.: HY-126161
CAS No.: 16985-03-8
Purity:  99.95%
Synonyms: BRL-4664
Target:  

Cannabinoid Receptor

Research Areas:  

Neurological Disease Cancer

Nonabine (BRL-4664) is an orally active chromenol derivative and Cannabinoid-like antiemetic. Nonabine controls nausea and vomiting induced by cancer chemotherapy regimens. Nonabine can be used in the research of lymphoma and chemotherapy-induced nausea and vomiting .
loading...
    loading...
Cat. No.: HY-N16985
CAS No.: 29803-90-5
Taraxasteryl palmitate is a taraxasterol-type triterpene ester compound with antiemetic activity. Intralymphatic injection of 30 mg/kg and 100 mg/kg Taraxasteryl palmitate significantly inhibited vomiting in a copper sulfate-induced frog vomiting model, with vomiting latency extension rates of 116.9% and 120.0%, respectively. Taraxasteryl palmitate exerts its anti-reflex vomiting activity by prolonging the vomiting latency. Taraxasteryl palmitate can be used in the study of vomiting-related diseases (especially reflex vomiting). Taraxasteryl palmitate can be naturally extracted from the flowers of Inula linariaefolia .
loading...
    loading...
Cat. No.: HY-124470
CAS No.: 550-28-7
Target:  

Others

Research Areas:  

Cardiovascular Disease

Amisometradine is an orally active aminouracil diuretic with a diuretic potency approximately 40% that of Mersalyl (HY-108868) (when administered intramuscularly). Amisometradine exerts its effects by promoting the excretion of sodium, chloride and a small amount of potassium, exhibits significant therapeutic effects in heart failure models, and has good tolerance with long-term administration. Compared with drugs of the same class, Amisometradine causes fewer gastrointestinal reactions; its minor side effects mainly include nausea, vomiting, diarrhea, tinnitus and deafness, and are usually not accompanied by proteinuria or abnormalities in blood and urine indicators. Amisometradine is an important tool for the study of heart failure and related diuretic mechanisms .
loading...
    loading...